Association of Optometrists (AOP)7h
Optometry's fundamental importance in global health
As part of World Optometry Week, OT heard from Dr Cindy Tromans, president-elect of the World Council of Optometry ...
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biopharmaceutical company developing important new therapies ...
PipelineReview.com12h
REGENXBIO reports positive biomarker data from AFFINITY DUCHENNE trial of RGX-202 gene therapy
ROCKVILLE, MD, USA I March 19, 2025 I REGENXBIO Inc. (Nasdaq: RGNX) today reported new, positive interim data from two additional patients in the Phase ...
Opus Genetics, Inc.: Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biopharmaceutical company developing important new therapies for the treatment ...
Ophthalmology Advisor1h
In-Human Trials Shows Artificial Lamellar Implant’s Ability to Treat Corneal Edema
The first in-human trials for an artificial lamellar implant demonstrates the device’s potential to treat corneal edema.
Mounrjaro hits shelves in India: How Eli Lilly’s anti-diabetes drug compares with Ozempic — price, side effects and more
Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...